Sight Sciences wins $55.4M patent verdict against Alcon plus 10% royalty, but payment uncertain

Filed April 23, 2026 · Period ending April 22, 2026 · ~1 min read

Key Changes

• high

  Court awarded $55.4M in damages for Alcon's willful infringement of three Hydrus Microstent patents, covering past sales through March 2026 plus interest. No payment until appeals exhausted.

  Item 8.01 view on EDGAR →
• high

  Ongoing 10% royalty on all Hydrus revenue awarded through patent expiration, creating potential recurring revenue stream if judgment survives appeal process.

  Item 8.01 view on EDGAR →
• high

  Alcon can appeal to Federal Circuit, delaying any payment potentially for years. Separate patent reexamination proceedings could invalidate claims and eliminate collection rights entirely.

  Item 8.01 view on EDGAR →